Abnous Podia Invest&Architect Inc. has begun operations as an R&D company that applies formulation technology to biomaterials and advances their implementation in architecture, infrastructure, and living environments.
The company was established on March 30, 2026 after founding support from STUDIO 10X, a partner program of TOKYO SUTEAM, the Tokyo Metropolitan Government's startup creation initiative. APIA is advancing material development and commercialization with an initial focus on the construction and architecture sectors.
Applying formulation technology to architecture and infrastructure materials
APIA applies formulation approaches developed in pharmaceutical and medical-device material development to the functionalization of unused biomass and natural-origin materials. The company aims to develop materials that balance reduced environmental impact, resource circulation, durability, workability, and design quality.
Business domains
- Advanced Biomaterials: R&D and supply of high-performance biomaterials.
- Material Licensing: IP development, process packaging, and licensing of material technologies.
- Project Development: Integrated design from technology seed selection to a marketable business plan.
Ongoing development themes
APIA is developing themes such as non-combustible and water-resistant wood, biomaterial wall coverings, natural-origin adhesives, bio deodorizers, and microbial formulations for architecture, infrastructure, and living environments.
Collaboration
APIA welcomes joint development with partners involved in unused resources, alternative materials, application development for material technologies, and domestic implementation of overseas technology seeds.